Open AccessA combination treatment of IFN-α2b and IFN-γ accelerates viral clearance and control inflammatory response in COVID-19: Preliminary results of a randomized controlled trial
Author(s) -
Idelsis Esquivel-Moynelo,
Jesus Perez-Escribano,
Yaquelín Duncan-Roberts,
Dania VázquezBlomquist,
Mónica BéquetRomero,
Lisandra Baez-Rodriguez,
Jesus Castro-Rios,
Lisbeth Cobas-Cervantes,
Ernesto Page-Calvet,
Saily Travieso-Perez,
C Martínez-Suárez,
Ivan Campa-Legrá,
Julio R. Fernández,
Hamlet Camacho-Rodriguez,
Marisol Diaz-Galvez,
Adriana Sin-Mayor,
Maura Garcia-Sanchez,
Sara Martinez-Martin,
Marel Alonso-Valdés,
Francisco Hernández-Bernal,
Hugo Nodarse-Cuní,
Dianela Bello-Garcia,
Camila Canaan-Haden Ayala,
Isabel Gonzales-Moya,
Abrahan Beato-Canfuk,
Tania Vizcaino-Cesar,
Gerardo Guillén,
Verena L. Muzio-González,
Eleanor N. Fish,
Iraldo Bello Rivero
Publication year - 2021
Publication title -
annals of antivirals and antiretrovirals
Language(s) - English
Resource type - Journals
ISSN - 2692-4625
DOI - 10.17352/aaa.000010
Subject(s) - medicine , randomized controlled trial , clinical trial , viral replication , viral load , immunology , virology , virus
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom